Have a personal or library account? Click to login
An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation Cover

An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation

Acta Pharmaceutica
Volume 71 (2021): Issue 1 (March 2021)
By: Navya Ajitkumar Bhaskaran,  Lalit Kumar,  M Sreenivasa Reddy and  Girish K Pai  
Open Access
|Jul 2020
DOI: https://doi.org/10.2478/acph-2021-0008 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 57 - 79
Accepted on: Apr 2, 2020
Published on: Jul 20, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
irinotecan,
HPLC-UV,
“quality by design”,
full factorial design,
Box-Behnken design
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Navya Ajitkumar Bhaskaran, Lalit Kumar, M Sreenivasa Reddy, Girish K Pai, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 71 (2021): Issue 1 (March 2021)Next article